Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study Comparing Lutetium (177Lu) rhPSMA-10.1 and Lutetium (177Lu) Vipivotide Tetraxetan for Patients with Advanced Prostate Cancer

    Not recruiting

    1 1 1 1
    France Germany The Netherlands Spain
  • Study of Fuzuloparib, Abiraterone Acetate, and Prednisone for First-Line Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    3 1 1
    Belgium Czechia France Hungary Poland Spain
  • Study of PF-06821497 with Enzalutamide for Men with Metastatic Castration-Resistant Prostate Cancer Previously Treated with Abiraterone Acetate

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Czechia France Germany Greece Hungary Italy +5
  • Study on Treating Metastatic Castration-Resistant Prostate Cancer with 177Lu-PNT2002 Compared to Abiraterone or Enzalutamide for Patients After Hormonal Therapy

    Not recruiting

    3 1 1 1
    France The Netherlands Sweden
  • Study on Radium-223, Docetaxel, and Prednisone for Patients with Bone-Only Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    2 1 1 1
    Italy
  • Study on Capivasertib and Docetaxel for Treating Metastatic Castration-Resistant Prostate Cancer in Patients

    Not recruiting

    3 1 1
    Investigated drugs:
    Belgium Czechia France Greece Hungary The Netherlands +2
  • Study on the Safety and Effects of PT-112 for Patients with Advanced Prostate Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    France
  • Study on Lutetium (177Lu) Vipivotide Tetraxetan for Men with Progressive Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    3 1 1 1
    Austria Belgium Czechia France Germany The Netherlands +3
  • Study Comparing Radium-223 Dichloride with Abiraterone Acetate, Enzalutamide, and Prednisone in Patients with Advanced Prostate Cancer Spread to the Bone

    Not recruiting

    3 1 1 1
    Austria Czechia Finland France Germany Hungary +4
  • Study of Olaparib and Abiraterone for Men with Advanced Prostate Cancer Resistant to Hormone Therapy

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Belgium Czechia France Italy The Netherlands Slovakia